Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
79 hedge funds and large institutions have $69M invested in Immunomedics Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 18 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
8% less call options, than puts
Call options by funds: $2.72M | Put options by funds: $2.96M
7% less funds holding
Funds holding: 85 → 79 (-6)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
59% less capital invested
Capital invested by funds: $166M → $69M (-$97.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$8.48M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.12M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$4.37M |
| 4 |
Goldman Sachs
New York
|
+$713K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$535K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$10.2M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
-$8.09M |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$6.09M |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.44M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.34M |
IMMU Hedge Fund Activity: Q3 2015 in Review
79 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2015, worth a combined $69M — down 59% from $166M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of IMMU and 13 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 27 added.
The largest buyer was OrbiMed, opening a new position worth an estimated $8.48M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.2M sold.
- 79 institutional investors held Immunomedics Inc (IMMU) as of Q3 2015, down from 85 in Q2 2015.
- Funds reported $69M of Immunomedics Inc stock for Q3 2015, down 59% quarter-over-quarter.
- 13 funds opened new Immunomedics Inc positions in Q3 2015 and 18 closed out, a net change of -5 holders.
- The largest Immunomedics Inc buyer in Q3 2015 was OrbiMed, an estimated $8.48M added.
- The largest Immunomedics Inc seller in Q3 2015 was Deerfield Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q3 2015.